These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23425429)

  • 1. The impact of short-term topical gatifloxacin and moxifloxacin on bacterial injection after hypodermic needle passage through human conjunctiva.
    Pettey JH; Mifflin MD; Kamae K; McEntire MW; Pettey DH; Callegan MC; Brown H; Olson RJ
    J Ocul Pharmacol Ther; 2013 Jun; 29(5):450-5. PubMed ID: 23425429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the Acute Effects of Povidone-Iodine on Conjunctival Bacterial Flora.
    Pettey JH; Mifflin MD; Olson RJ
    J Ocul Pharmacol Ther; 2015 Dec; 31(10):627-30. PubMed ID: 26287981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial efficacy of prophylactic gatifloxacin 0.3% and moxifloxacin 0.5% in patients undergoing phacoemulsification surgery.
    Bucci FA; Amico LM; Evans RE
    Eye Contact Lens; 2008 Jan; 34(1):39-42. PubMed ID: 18180682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ophthalmic antibiotic use and multidrug-resistant staphylococcus epidermidis: a controlled, longitudinal study.
    Dave SB; Toma HS; Kim SJ
    Ophthalmology; 2011 Oct; 118(10):2035-40. PubMed ID: 21856006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections.
    Moss JM; Sanislo SR; Ta CN
    Ophthalmology; 2009 Aug; 116(8):1498-501. PubMed ID: 19501409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection.
    Milder E; Vander J; Shah C; Garg S
    Ophthalmology; 2012 Jul; 119(7):1420-4. PubMed ID: 22420958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis.
    Sanders ME; Norcross EW; Moore QC; Shafiee A; Marquart ME
    Cornea; 2009 Oct; 28(9):1055-60. PubMed ID: 19724203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.
    Proksch JW; Ward KW
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):449-58. PubMed ID: 20874668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures.
    Fintelmann RE; Hoskins EN; Lietman TM; Keenan JD; Gaynor BD; Cevallos V; Acharya NR
    Arch Ophthalmol; 2011 Apr; 129(4):399-402. PubMed ID: 21482865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility comparisons of normal preoperative conjunctival bacteria to fluoroquinolones.
    Hori Y; Nakazawa T; Maeda N; Sakamoto M; Yokokura S; Kubota A; Inoue T; Nishida K; Tano Y
    J Cataract Refract Surg; 2009 Mar; 35(3):475-9. PubMed ID: 19251140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens.
    Callegan MC; Ramirez R; Kane ST; Cochran DC; Jensen H
    Adv Ther; 2003; 20(5):246-52. PubMed ID: 14964344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibilities of bacterial isolates from conjunctival flora to gatifloxacin, levofloxacin, tosufloxacin, and moxifloxacin.
    Yamada M; Hatou S; Yoshida J
    Eye Contact Lens; 2008 Mar; 34(2):109-12. PubMed ID: 18327047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro antibiotic susceptibility to fluoroquinolones].
    Wong CA; Galvis V; Tello A; Villareal D; Rey JJ
    Arch Soc Esp Oftalmol; 2012 Mar; 87(3):72-8. PubMed ID: 22423655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients.
    Kim DH; Stark WJ; O'Brien TP; Dick JD
    Ophthalmology; 2005 Nov; 112(11):1992-6. PubMed ID: 16183125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.
    Callegan MC; Novosad BD; Ramadan RT; Wiskur B; Moyer AL
    Adv Ther; 2009 Apr; 26(4):447-54. PubMed ID: 19381523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in ocular flora in eyes exposed to ophthalmic antibiotics.
    Dave SB; Toma HS; Kim SJ
    Ophthalmology; 2013 May; 120(5):937-41. PubMed ID: 23415422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones.
    Segreti J; Jones RN; Bertino JS
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):3-11. PubMed ID: 21999341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antibiotic susceptibility of preoperative normal conjunctival bacteria.
    Ta CN; He L; Mino de Kaspar H
    Eye (Lond); 2009 Mar; 23(3):559-60. PubMed ID: 18356928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity of acrylic intraocular lenses soaked in fourth generation fluoroquinolones.
    Smith EF; Elbash AR; Schrier A; Berg PD; Eid I
    J Ocul Pharmacol Ther; 2008 Oct; 24(5):495-500. PubMed ID: 18803443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates.
    Harper T; Miller D; Flynn HW
    Ophthalmology; 2007 May; 114(5):871-5. PubMed ID: 17383732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.